CYTK | Cytokinetics, Inc. (NASDAQ:CYTK) Expected to Announce Quarterly Sales of $3.80 Million

Wall Street analysts expect Cytokinetics, Inc.(NASDAQ:CYTK) to report $3.80 million in sales for the current quarter, Zacks reports.Two analysts have issued estimates for Cytokinetics’ earnings, with the lowest sales estimate coming in at $3.60 million and the highest estimate coming in at $4.00 million.Cytokinetics posted sales of $6.06 million in the same […]The Olympia Report